Your browser doesn't support javascript.
loading
Novel Clinical Tool to Estimate Risk of False-Negative KRAS Mutations in Circulating Tumor DNA Testing.
Napolitano, Stefania; Parikh, Aparna R; Henry, Jason; Parseghian, Christine M; Willis, Jason; Raghav, Kanwal P; Morris, Van K; Johnson, Benny; Kee, Bryan K; Dasari, Arvind N; Overman, Michael J; Luthra, Raja; Drusbosky, Leylah M; Corcoran, Ryan B; Kopetz, Scott; Sun, Ryan.
Affiliation
  • Napolitano S; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy.
  • Parikh AR; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Henry J; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA.
  • Parseghian CM; Sarah Cannon Research Institute, Denver, CO.
  • Willis J; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Raghav KP; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Morris VK; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Johnson B; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Kee BK; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Dasari AN; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Overman MJ; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Luthra R; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Drusbosky LM; Department of Hematopathology, Division of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Corcoran RB; Guardant Health, Inc, Redwood City, CA.
  • Kopetz S; Department of Medicine, Harvard Medical School, Boston, MA.
  • Sun R; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
JCO Precis Oncol ; 7: e2300228, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37824798
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms / Circulating Tumor DNA Limits: Humans Language: En Journal: JCO Precis Oncol Year: 2023 Document type: Article Affiliation country: Italia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms / Circulating Tumor DNA Limits: Humans Language: En Journal: JCO Precis Oncol Year: 2023 Document type: Article Affiliation country: Italia